Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
bioRxiv : the preprint server for biology(2023)
Abstract
Broad target inhibition effective as a salvage strategy in BRAF/MEK inhibitor-acquired resistance PDX.
MoreTranslated text
Key words
mapk,standard-of-care
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined